Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Izotropic Corp (CSE:IZO)

0.3000 UNCHANGED
Streaming Delayed Price Updated: 3:35 PM EDT, Aug 28, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Izotropic Corp

< Previous 1 2 Next >
InvestorNewsBreaks – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) Integrates Proprietary AI Algorithm into Breast CT Imaging System
Via Investor Brand Network
Topics Artificial Intelligence
Izotropic’s AI Breakthrough Positions IzoView to Redefine Breast CT Imaging Standards
From Izotropic
Via GlobeNewswire
Izotropic Corp. (CSE: IZO) (OTCQB: IZOZF) Unveils Comprehensive Brand Identity Transformation to Position Company for Commercial Launch
Via Investor Brand Network
TechMediaBreaks – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) Announces $300K Private Placement and Warrant Extension
Via Investor Brand Network
InvestorNewsBreaks – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) Launches BreastCT.com to Advance Awareness of Dedicated Breast CT Technology
Via Investor Brand Network
Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF): How a $500K Device Could Reshape the $8.7 Billion Breast Imaging Market
Via Investor Brand Network
BreastCT.com Debuts as Go-To Resource for Breast CT Technology & Izotropic’s IzoView Device
From Izotropic
Via GlobeNewswire
TechMediaBreaks – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) Launches New Corporate Website and Brand Identity
Via Investor Brand Network
Izotropic Corp. (CSE: IZO) (OTCQB: IZOZF): The Cancer Detection Revolution That Could Make Breast Cancer Deaths Preventable
Via Investor Brand Network
Topics Death
Izotropic Corp. (CSE: IZO) (OTCQB: IZOZF) Advancing Next-Gen Breast Cancer Imaging
Via Investor Brand Network
BioMedNewsBreaks – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) Launches Multilingual Podcast to Raise Awareness of Breast Imaging Innovation
Via Investor Brand Network
Izotropic Launches Podcast Episode #1: Beyond the Mammogram: Rethinking the Future of Breast Imaging
From Izotropic
Via GlobeNewswire
BioMedNewsBreaks — Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) Highlights Market Demand for Breast CT Imaging Innovation
Via Investor Brand Network
Izotropic’s IzoView Positioned to Capitalize on Key Global Breast Imaging Market Drivers
From Izotropic
Via GlobeNewswire
Why Izotropic Corp. (CSE: IZO) (OTCQB: IZOZF) Is ‘One to Watch’
Via Investor Brand Network
TechMediaBreaks – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) Highlights IzoView Breast CT Advantages Over Existing Imaging Technologies
Via Investor Brand Network
Izotropic’s IzoView Breast CT Device Stands Distinct vs Existing Breast Imaging Technologies
From Izotropic
Via GlobeNewswire
InvestorNewsBreaks – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) Launches Strategic Awareness Campaign Ahead of IzoView Breast CT Commercialization
Via Investor Brand Network
Life Science Virtual Investor Forum: Presentations Now Available for Online Viewing
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
Life Sciences Investor Forum Agenda Announced for March 13th
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
Small Cap Growth Virtual Investor Conference Agenda Announced for February 6th
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
Izotropic to Present at Investor Conference February 6th
From Virtual Investor Conferences
Via GlobeNewswire
Izotropic Files Pre-Submission with U.S. FDA for Breast Cancer Screening
-A screening indication for women with dense breast tissue adjunctive to 3D mammography increases the market size for annual IzoView... 
Via Newsfile
Izotropic Provides Regulatory and Operational Updates
VANCOUVER, BC – TheNewswire - January 8, 2024 – Izotropic Corporation (“Izotropic” or the “Company”) (CSE:IZO) (OTC:IZOZF) (FSE:1R3), a medical device company commercializing IzoView, a CT (computed... 
Via TheNewswire.com
Izotropic Announces AGM Results
VANCOUVER, BC – TheNewswire - December 22, 2023 – Izotropic Corporation (“Izotropic” or the“Company”) (CSE:IZO) (OTC:IZOZF) (FSE:1R3), a medical device company commercializing IzoView, a CT (computed... 
Via TheNewswire.com
Izotropic Completes Pre-Submission Meeting With U.S. FDA
VANCOUVER, BC, November 1, 2023 – TheNewswire – Izotropic Corporation (“Izotropic” or the “Company”) (CSE:IZO) (OTC:IZOZF) (FSE:1R3), a medical device company commercializing IzoView, a CT (computed... 
Via TheNewswire.com
Izotropic Confirms FDA Pre-Submission Meeting Date
Vancouver, BC - TheNewswire - September 27, 2023 - Izotropic Corporation (“Izotropic” or the “Company”) (CSE:IZO) (OTC:IZOZF) (FSE:1R3), a medical device company commercializing IzoView, a CT (computed... 
Via TheNewswire.com
Izotropic Closes Non-Brokered Private Placement
Vancouver, BC - TheNewswire - September 20, 2023 - Izotropic Corporation (“Izotropic” or the “Company”) (CSE: IZO) (OTCQ: IZOZF) (FSE: 1R3), a medical device company commercializing IzoView, a CT... 
Via TheNewswire.com
Izotropic Corporation Announces Non-Brokered Private Placement
Vancouver, BC - TheNewswire - September 13, 2023 - Izotropic Corporation (“Izotropic” or the “Company”) (CSE:IZO) (OTC:IZOZF) (FSE:1R3), a medical device company commercializing IzoView, a CT (computed... 
Via TheNewswire.com
Izotropic Files Class II Pre-Submission with FDA & Releases Details on Predicate Devices
 
Via TheNewswire.com
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.